Anja Welt

1.4k total citations
42 papers, 639 citations indexed

About

Anja Welt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Anja Welt has authored 42 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Anja Welt's work include Advanced Breast Cancer Therapies (20 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Cancer Treatment Studies (12 papers). Anja Welt is often cited by papers focused on Advanced Breast Cancer Therapies (20 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Cancer Treatment Studies (12 papers). Anja Welt collaborates with scholars based in Germany, United States and France. Anja Welt's co-authors include Mitra Tewes, Rainer Kimmig, Sabine Kasimir‐Bauer, Bahriye Aktas, Siegfried Hauch, S. Seeber, Ullrich Graeven, Miriam König, W. Schmiegel and S. Petrasch and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Anja Welt

35 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Welt Germany 13 457 218 213 79 72 42 639
Matt Truman Australia 12 269 0.6× 337 1.5× 393 1.8× 101 1.3× 36 0.5× 25 632
Claudia Andreetta Italy 16 517 1.1× 296 1.4× 205 1.0× 162 2.1× 38 0.5× 41 831
Tareq Al Baghdadi United States 12 415 0.9× 175 0.8× 217 1.0× 196 2.5× 64 0.9× 35 593
L. Cals France 15 495 1.1× 102 0.5× 253 1.2× 79 1.0× 109 1.5× 41 674
Yoojoo Lim South Korea 14 201 0.4× 127 0.6× 117 0.5× 162 2.1× 36 0.5× 56 485
Smitha Menon United States 11 300 0.7× 73 0.3× 128 0.6× 134 1.7× 29 0.4× 18 474
U. Klaassen Germany 14 642 1.4× 203 0.9× 130 0.6× 115 1.5× 78 1.1× 31 777
F. Nolè Italy 7 467 1.0× 269 1.2× 163 0.8× 235 3.0× 27 0.4× 12 686
Robert D. Legare United States 14 449 1.0× 230 1.1× 68 0.3× 150 1.9× 27 0.4× 35 822
Arnd Nusch Germany 14 437 1.0× 215 1.0× 476 2.2× 126 1.6× 41 0.6× 50 729

Countries citing papers authored by Anja Welt

Since Specialization
Citations

This map shows the geographic impact of Anja Welt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Welt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Welt more than expected).

Fields of papers citing papers by Anja Welt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Welt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Welt. The network helps show where Anja Welt may publish in the future.

Co-authorship network of co-authors of Anja Welt

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Welt. A scholar is included among the top collaborators of Anja Welt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Welt. Anja Welt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welt, Anja, Hans‐Christian Kolberg, Oliver Hoffmann, et al.. (2025). Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy. Scientific Reports. 15(1). 10347–10347. 1 indexed citations
2.
Thill, Marc, Anja Welt, Arnd Nusch, et al.. (2024). Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of HR‐positive/HER2‐negative metastatic breast cancer with real‐world data from the OPAL registry. International Journal of Cancer. 156(9). 1770–1782. 5 indexed citations
3.
Ruckhäberle, Eugen, Marcus Schmidt, Anja Welt, et al.. (2024). Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer. Geburtshilfe und Frauenheilkunde. 84(9). 813–836. 2 indexed citations
4.
Wiesweg, Marcel, Sebastian Bauer, Anja Welt, et al.. (2023). Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients. Cancers. 15(11). 3029–3029. 7 indexed citations
5.
Hegedüs, Luca, Fabian Mairinger, Till Ploenes, et al.. (2023). TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy. Lung Cancer. 178. 237–246. 7 indexed citations
6.
Marschner, Norbert, Nadia Harbeck, Elmar Stickeler, et al.. (2022). 232P Second-line therapies of patients with early progression under CDK4/6-inhibitor in first-line – data from the registry platform OPAL. Annals of Oncology. 33. S643–S644. 3 indexed citations
7.
8.
Welt, Anja, Marc Thill, Elmar Stickeler, et al.. (2020). 324P What affects the choice of first-line treatment for hormone-receptor-positive, HER2-negative advanced breast cancer? Data from the German research platform OPAL. Annals of Oncology. 31. S373–S374. 2 indexed citations
9.
Welt, Anja, Simon Bogner, Marina Arendt, et al.. (2020). Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center. Journal of Cancer Research and Clinical Oncology. 146(6). 1559–1566. 15 indexed citations
10.
Harbeck, Nadia, Norbert Marschner, Michael Untch, et al.. (2014). Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective. Breast Care. 9(1). 52–59. 7 indexed citations
11.
Tewes, Mitra, Sabine Kasimir‐Bauer, Anja Welt, et al.. (2014). Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer. Journal of Cancer Research and Clinical Oncology. 141(1). 87–92. 8 indexed citations
12.
Thomssen, Christoph, Norbert Marschner, Michael Untch, et al.. (2012). ABC1 Consensus Conference – a German Perspective. Breast Care. 7(1). 52–59. 4 indexed citations
13.
Heinemann, Volker, Dorit Di Gioia, Ursula Vehling‐Kaiser, et al.. (2010). A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer. Annals of Oncology. 22(3). 603–608. 19 indexed citations
14.
15.
Welt, Anja & S. Seeber. (2005). Systematische oder symptomorientierte Nachsorge bei Frauen mit Mammakarzinom. Zentralblatt für Gynäkologie. 127(4). 213–216.
16.
Welt, Anja, Gϋnter von Minckwitz, C. Oberhoff, et al.. (2004). Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. Annals of Oncology. 16(1). 64–69. 56 indexed citations
17.
Bojko, Peter, Anja Welt, Regina Schleucher, et al.. (2004). High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer. Bone Marrow Transplantation. 34(7). 637–643. 10 indexed citations
18.
Petrasch, S., et al.. (1998). Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer. British Journal of Cancer. 78(4). 511–514. 65 indexed citations
19.
Kasper, Christoph, et al.. (1997). Recombinant human erythropoietin in the treatment of cancer‐related anaemia. European Journal Of Haematology. 58(4). 251–256. 21 indexed citations
20.
Siebert, Reiner, Alexander Fosså, Anja Welt, et al.. (1997). Recurrence of hodgkin's disease after 10 or more years: Late relapse or de-Novo malignancy due to HLA-DPB1* 0301-linked susceptibility?. Leukemia & lymphoma. 26(1-2). 121–125. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matt Truman Breakdown of academic impact, for papers by Claudia Andreetta Breakdown of academic impact, for papers by Tareq Al Baghdadi Breakdown of academic impact, for papers by L. Cals Breakdown of academic impact, for papers by Yoojoo Lim Breakdown of academic impact, for papers by Smitha Menon Breakdown of academic impact, for papers by U. Klaassen Breakdown of academic impact, for papers by F. Nolè Breakdown of academic impact, for papers by Robert D. Legare Breakdown of academic impact, for papers by Arnd Nusch
Rankless by CCL
2026